OSE Immunotherapeutics SA (EPA:OSE)
France · Delayed Price · Currency is EUR 2.114
-0.060 (-2.76%)
Oct 2, 2026, 5:35 PM CET
OSE Immunotherapeutics Market Cap
OSE Immunotherapeutics has a market cap or net worth of €49.72 million as of October 2, 2026. Its market cap has decreased by -69.20% in one year.
Market Cap
49.72M
Enterprise Value
63.37M
Revenue
2.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.11
ChartMarket Cap Chart
Since March 30, 2015, OSE Immunotherapeutics's market cap has decreased from 104.30M to 49.72M, a decrease of -52.33%. That is a compound annual growth rate of -6.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 49.72M | -56.94% |
| Dec 31, 2025 | 115.47M | -26.37% |
| Dec 31, 2024 | 156.83M | 94.71% |
| Dec 29, 2023 | 80.55M | -34.73% |
| Dec 30, 2022 | 123.40M | -34.26% |
| Dec 31, 2021 | 187.71M | 45.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 131.37M |
| Cellectis | 97.05M |
| Sensorion | 75.06M |
| ABIONYX Pharma | 74.52M |
| Adocia | 48.33M |
| THX Pharma Société Anonyme | 47.05M |
| Fermentalg | 42.84M |
| Nicox | 29.44M |